Best Therapeutic Apheresis Doctors in test — TOP 13

Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.

• National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
• Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
• Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
• Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.

National renowned authority in nephrology with 30+ years of experience. Prof. Zhang specializes in therapeutic apheresis at Xiamen Humanity Hospital.

• Deputy Chairperson of Immunoadsorption and Cell Therapy Group
• Participated in multiple National Natural Science Foundation projects
• Author of 30+ publications, including 6 SCl-indexed papers
• Expertise in renal replacement therapies including hemodialysis
• Standing Committee Member in multiple national nephrology associations

Dr. Pazit Beckerman is the head of the Israeli Dialysis Registry. She works at Sheba Medical Center, a hospital ranked 7th globally. She specializes in chronic kidney disease and complex dialysis management. Dr. Beckerman completed a postdoctoral fellowship at the University of Pennsylvania.

• Served as Acting Director of Nephrology at Sheba Medical Center.
• Treats acute kidney injury and hypertension-related renal disease.
• Expert in glomerular diseases, protein loss, and electrolyte disorders.
• Board member of the Israeli Society of Nephrology and Hypertension.

Dr. Ilhan Mavioglu is a cardiovascular surgeon at Optimed International Hospital. He leads the Cardiovascular Surgery Outpatient Clinic. He performs minimally invasive anaortic coronary bypass and awake carotid surgery. Dr. Mavioglu holds a Professorship from Düzce University and trained at Great Ormond Street Hospital. He specializes in total arterial revascularization and complex endovascular interventions.

• Certified in robotic mitral valve repair and endovascular surgical techniques.
• Performs EVAR, FEVAR, and CERAB procedures for peripheral vascular conditions.
• Member of the European Association of Cardiovascular Surgery.
• Maintains over 400 scientific publications in journals like J Card Surg.

Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.

• Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
• Authored over 240 scientific publications in pediatric hemato-oncology.
• Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
• Leads the integration of CAR T–cell therapy with bone marrow transplantation.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Eyup Koc is an internist and nephrologist. He studied at Istanbul University – Cerrahpaşa Faculty of Medicine from 1980 to 1986. He completed his residency in Internal Medicine at Izmir Atatürk Training and Research Hospital from 1989 to 1994. He then specialized in Nephrology at Gazi University Faculty of Medicine from 2005 to 2008.

Clinical interests include hypertension, acute kidney failure, chronic kidney failure, hemodialysis, peritoneal dialysis, kidney transplantation, glomerulonephritis, and diabetic kidney disease.

Dr. Kadri Yamac is an internist and hematologist. He earned his medical degree from Ankara University Faculty of Medicine (1976–1982). He completed Internal Medicine training at Gazi University Faculty of Medicine (1984–1989). He then completed a Hematology subspecialty at Gazi University Faculty of Medicine (1990–1993). He became an Associate Professor at Gazi University Faculty of Medicine in 1995. He was promoted to Professor in 2002.

Medical interests: anemias, coagulation disorders, hemochromatosis, chronic lymphocytic leukemia, lymph node diseases, non-Hodgkin lymphoma, Hodgkin lymphoma.

The doctor is a distinguished cardiology specialist with extensive clinical experience, having earned a medical degree from Hacettepe University in 2004 and completed cardiology specialization at Gazi University in 2010. Achieving the rank of Professor in 2024, the doctor has served at several prominent institutions, including Ankara Turkey Higher Specialized Hospital and Ankara Bilkent City Hospital.

The doctor specializes in preventive cardiology, hyperlipidemia, hypertension, and heart failure, with significant expertise in interventional procedures such as coronary angiography, stent and balloon treatments, and complex coronary interventions. The doctor is also skilled in cardio-oncology, rhythm disorders, and advanced imaging techniques like TEE.